IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RHO Capital Partners Inc

Q3 2019 Holdings

Filed 2019-11-12 | 5 holdings | $119.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cara Therapeutics Inc(CARAEUR)COM140755109$58.4K3,193,05748.9%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$52.2K3,766,66743.7%
Livexlive Media IncCOM NEW53839L208$7.5K3,724,1386.3%
Mersana Therapeutics IncCOM59045L106$1.3K796,4581.1%
Senseonics Hldgs Inc(SENS1GBP)COM81727U105$158159,6010.1%